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Cytokine-induced expression of tPA is differentially
modulated by NO and ROS in rat mesangial cells
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Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universita¨t, Frankfurt am Main, Germany
Cytokine-induced expression of tPA is differentially modulated graft rejection, diabetic nephropathy and certain forms
by NO and ROS in rat mesangial cells. of immune-mediated glomerulonephritis [1, 2]. A major
Background. Dysregulated expression of diverse proteases source of glomerular NO production is the mesangialand their specific inhibitors is critical for the increase in extra-
cell (MC), which upon activation with inflammatory cy-cellular matrix accumulation that accompanies chronic inflam-
tokines such as interleukin-1 (IL-1) and tumor necro-matory and sclerotic processes within the renal mesangium.
Within the activating cascade of several proteases, the plasmin- sis factor- (TNF-) can produce high levels of NO
ogen system plays an important role. mainly by the action of the inducible form of nitric oxide
Methods. We tested for modulatory effects of the nitric oxide synthase (iNOS) [3]. MCs are a primary constituent of(NO) donors S-nitroso-N-acetyl-D,L-penicillamine and DETA-
the glomerular architecture, as they support the struc-NONOate, and the superoxide-generating system hypoxan-
tural and functional integrity of the glomerulus due tothine/xanthine oxidase (HXXO) on the expression and activity
of tissue plasminogen activator (tPA) by ELISA and Northern their smooth muscle cell properties. Moreover, MCs are
blotting. the main producers of the glomerular extracellular ma-
Results. Interleukin-1 (IL-1)-induced tPA and plasmino- trix (ECM) [4]. Recent studies have suggested that in
gen activator inhibitor (PAI)-1 mRNA and supernatant tPA
addition to structural support, the mesangial matrix af-antigen were significantly inhibited by both NO donors, which
fects a variety of cell functions essentially involved in theresulted in a net decrease in the IL-1-evoked tPA enzyme
activity in the conditioned media. Addition of the NO-synthase progression of several glomerular diseases [5]. Central to
inhibitor N-monomethyl l-arginine markedly increased the cy- these processes are the actions of different proteinases
tokine-triggered tPA- and PAI-1 mRNA levels, respectively. that regulate the turnover of ECM by degradation of
In contrast, HXXO caused a marked amplification of the IL-1-
specific ECM components, mainly collagens, laminin,induced steady-state tPA mRNA level and tPA enzyme activity
proteoglycans and fibronectin. Two main classes of pro-that was blocked by catalase. Since MnTBAP, a superoxide dis-
mutase mimetic, had no effects on the amplification of mRNA teinases have been described to be of importance for
levels, we suggest that H2O2 is the candidate reactive oxygen glomerular ECM degradation: (1) the family of metal-
species (ROS) responsible for the potentiation of IL-1–trig- dependent, neutral proteinases, denoted as matrix metal-
gered tPA and PAI-1 expression.
loproteinases (MMPs) [6], and (2) a class of metal-inde-Conclusions. The temporal relationship between NO and
pendent serine proteinases, which regulate the activityROS generation is a critical step in the modulation of tPA and
PAI-1 expression in mesangial cells and may account for a of the plasminogen/plasmin system and which are de-
dysregulation of matrix turnover during inflammatory pro- nominated as plasminogen activators (PAs) [7, 8]. An
cesses in the renal mesangium. excessive deposition of glomerular fibrin is considered
as a critical step in the progression of glomerular injury.
In addition to the degradation of fibrin, especially the
Nitric oxide (NO) has been described as a pleiotropic tissue-type of plasminogen activator (tPA) has been
messenger molecule implicated in the pathogenesis of a shown to degrade a variety of other ECM components
variety of inflammatory renal diseases, including renal including type IV collagen, laminin, fibronectin, and pro-
teoglycans [9, 10]. The ECM degradation by cultured
MCs involves a proteolytic enzyme cascade in which
Key words: extracellular matrix, nitric oxide, plasminogen activator
plasmin is one of the initiating activators of severalinhibitor, tissue plasminogen activator, superoxide, reactive oxygen
species, hydrogen peroxide, mesangial cells. MMPs, including MMP-2 and MMP-9.
Searching for possible targets of NO, we have pre-Received for publication March 29, 2001
viously reported that NO can modulate the expressionand in revised form July 24, 2001
Accepted for publication July 27, 2001 of cytokine-induced MMP-9 and its inhibitor, the tissue
inhibitor of metalloprotease-1 (TIMP-1), in rat MCs [11]. 2002 by the International Society of Nephrology
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Increased expression of tPA and its endogenous inhibi- Measurement of tPA activity in MCs
tor, the plasminogen activator inhibitor-1 (PAI-1), by Quantitative determination of tPA activity in cellular
proinflammatory cytokines such as IL-1 and TNF- has supernatants was done using the Chromolize tPA-ELISA
been demonstrated for a variety of different cell types, from Biopool (Umea, Sweden). Confluent MCs (1.0 to
including vascular endothelial cells [12] and human MCs 1.5  106 cells) on six-well plates were incubated in
[13]. Meanwhile, a quite heterogenous panel of genes DMEM without FCS and stimulated with or without
has been shown to be under the regulatory control of agents for the indicated time period. Thereafter, 100 L
NO, including those coding for structural proteins, pro- of the supernatants were directly applied to the microtest
inflammatory mediators and protective antioxidant de- strip wells of the enzyme-linked immunosorbent assay
fense enzymes [14]. Modulatory effects of NO on the (ELISA). Further procedures were performed following
expression pattern of cytokine-inducible genes involved the manufacturer’s instructions. The absorbance at 405
in the acute inflammatory response may be a critical step nm with a reference wavelength at 495 nm was used and
in the generation and outcome of acute and chronic tPA activity determined using human single-chain tPA
inflammatory processes in the kidney. Similar to NO, as a standard.
reactive oxygen species (ROS) are released from a vari-
ety of professional inflammatory cells as well as from Determination of tPA antigen in conditioned media
the resident MCs, mainly after activation by proinflam- Levels of tPA antigen in cell culture supernatants were
matory cytokines [15]. We recently reported on the am- determined by the Tint Elize tPA ELISA from Biopool.
plification of IL-1-induced MMP-9 expression by ROS, Confluent MCs (1.0 to 1.5  106 cells) on six-well plates
particularly by superoxide, in glomerular MCs [16]. Our were incubated in DMEM without FCS and stimulated
current study evaluated the effects of NO and ROS on with or without agents for the indicated time period.
the tPA/PAI-1 system under conditions where MCs dis- Twenty microliters of conditioned media were directly
play increased proteolytic capacities. transferred into the microtest strip wells of the ELISA
plate. Further procedures were performed following the
manufacturer’s instructions. The absorbance at 492 nmMETHODS
was measured in a microtest plate spectrophotometerCell culture
and tPA levels were determined with a calibration curve
Rat glomerular MCs were cultured as described pre-
using human tPA as a standard.viously [11]. MCs were grown in RPMI 1640 supple-
mented with 10% heat-inactivated fetal calf serum (FCS), Measurement of nitrite in cell culture supernatants
2 mmol/L glutamine, 5 ng · mL1 insulin, 100 U · mL1
Nitrite, the stable end product of NO, was measured inpenicillin and 100 g · mL1 streptomycin. Serum-free
the conditioned medium with the Griess reagent (Merck,preincubations were performed in Dulbecco’s modified
Darmstadt, Germany).Eagle’s medium (DMEM) supplemented with 2 mmol/L
glutamine, 0.1 mg · mL1 of fatty acid-free bovine serum cDNA clones and plasmids
albumin for 24 hours before cytokine treatment. For the
A cDNA insert of 0.72 kb of rat tPA was generatedexperiments, 3.0 to 5.0  106 cells per 10 cm culture dish
by reverse transcription (RT) from mRNA of MCs stim-were used between passages 8 and 20. All supplements
ulated with IL-1 using internal primers from the com-were purchased from GIBCO/BRL, Life Technologies
plete sequence of rat mRNA (deposited in the Genbank/(Eggenstein, Germany). The NO-donors S-nitroso-N-ace-
EMBL Databases, accession no. M 23697). The followingtyl-D,L-penicillamine (SNAP) and DETA-NONOate,
primers were used: 5-AGC AAA ATG AAG GGAthe NOS inhibitor NG-monomethyl l-arginine (L-NMMA)
GAG CTG-3 (sense) and 5-ATC ATG GAA TTCand Manganese-tetrakis (4-benzoic acid) porphyrin (Mn-
CAT GGG AGG-3 (anti-sense). The blunt ended PCRTBAP) were from Alexis Biochemicals (Gru¨nberg, Ger-
fragment was cloned into the EcoRV cloning site ofmany). N2, 2-O-dibutyrylguanosine3:5-cyclic monophos-
pBluescript-II KS (Stratagene GmbH, Heidelberg, Ger-phate was from Sigma-Aldrich (Deisenhofen, Germany).
many) to generate “pKS-tPA-rat.” A cDNA insert ofXanthine oxidase, hypoxanthine and catalase were pur-
0.9 kb of rat PAI-1 was generated using internal primerschased from Roche (Mannheim, Germany). Dimethoxy-
from the complete sequence of rat PAI-1 mRNA (acces-1,4-naphtoquinone (DMNQ) and glucose oxidase (from
sion no. M 24067) and cloned into EcoRV/HindIII-cutAsperigillus niger) were purchased from Calbiochem Nova-
pBluescript-II KS to generate “pKS-PAI-1-rat.” Thebiochem (Bad Soden, Germany). Actinomycin-D (from
following primers were used: 5-TGA TCG CCC GATStreptomyces species) was purchased from Sigma. Deter-
ATC AAG CCT-3 (sense); 5-CAT ACC CCC AGCmination of cell numbers was done using a Neubauer
TAG GAA GCT-3 (anti-sense). cDNA inserts for ratchamber. Cell cytotoxicity was measured as described
previously [11]. MMP-9, TIMP-1 and GAPDH were generated as de-
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scribed previously [11]. The cDNA insert from mouse tPA mRNA level by SNAP; Fig. 1B). Since the active
form of tPA is inhibited by the specific serine proteinase18S ribosomal RNA was obtained from Ambion (Austin,
TX, USA). inhibitor, the plasminogen activator inhibitor-1 (PAI-1),
we therefore checked whether the expression of PAI-1
Northern blot analysis also was influenced by the NO donor. To our surprise,
PAI-1 followed a similar biphasic regulation of expres-Total cellular RNA was extracted from MCs using the
Trizol reagent (GIBCO/BRL, Life Technologies). After sion as that seen for tPA (Fig. 1A). Coincubation of cells
with 500 mol/L SNAP and 2 nmol/L IL-1 caused aultraviolet (UV) cross-linking, 20 g of total RNA was
successively hybridized to 32P-labeled SacI/KpnI digested marked increase of IL-1 induced PAI-1 mRNA after 12
hours, but again a pronounced attenuation of cytokine-cDNA clones described above, thereby liberating inserts
of corresponding fragment sizes. cDNA probes (2  106 induced PAI-1 mRNA level was observed at 24 and 36
hours (Fig. 1 A, C). Inhibitory effects of SNAP on PAI-1cpm · mL1) were radioactively labeled with 32PdCTP
(Amersham Pharmacia Biotech, Freiburg, Germany) by steady-state mRNA level were maximal after 36 hours
of coincubation (Fig. 1A). There was no significant alter-random priming. To correct for variations in RNA amounts
blots were finally rehybridized with a 32P-labeled SacI/ ation of cell viability, as measured by trypan blue exclu-
sion and lactate dehydrogenase release, by any of theKpnI insert from a human GAPDH cDNA clone (acces-
sion no. NM 002046). Membranes used for RNA trans- experimental conditions (data not shown).
To monitor the level of tPA antigen secreted into thefers were obtained from NENTM Life Science Products
(Boston, MA, USA). Specific signals were quantified densi- supernatants, the content of tPA protein in the condi-
tioned media withdrawn after different durations of stim-tometrically using an automated detector system BAS
1500 from Fujifilm (Raytest, Straubenhardt, Germany). ulation was additionally measured (Fig. 1D). Similar to
the mRNA level, the IL-1–evoked increase of tPA was
Statistical analysis maximal after 24 hours of stimulation. Surprisingly, the
IL-1-induced level of tPA antigen did not follow a bi-Results are expressed as means  SD The data are
presented as an x-fold induction compared to control phasic expression pattern, but was reduced by SNAP at
all times points examined (Fig. 1D).conditions or compared to the IL-1-stimulated values.
Statistical analysis was performed using the Student t test As an internal control the expression pattern of
MMP-9 and its endogenous inhibitor TIMP-1 was alsoand analysis of variance (ANOVA) test for significance.
P values 	0.05 and 	0.01 were considered significant. examined, since the expression of both genes was nega-
tively modulated by NO in rat MCs [11]. Rehybridization
of the same blot with a MMP-9–specific cDNA probe
RESULTS
revealed that even after IL-1 stimulation the MMP-9
Effects of NO donors on mRNA levels of tPA and its mRNA steady-state level could not be detected before
endogenous inhibitor PAI-1 24 hours by Northern blotting; thus, it displayed a more
delayed expression kinetics when compared to tPAThe family of plasminogen activators (PA) comprises
two members of serine proteases, the tissue-type PA (Fig. 1A). As demonstrated previously, the amount of
IL-1-induced MMP-9 transcripts were strongly attenu-(tPA) and the urokinase-type PA (uPA), which both
exhibit fibrinolytic activity in human MCs [17]. IL-1 ated by NO after long-term stimulations (Fig. 1A). Inter-
estingly, the mRNA level of TIMP-1 followed a biphasicstrongly increased the mRNA level of tPA and its cog-
nate inhibitor PAI-1 in rat MCs (Fig. 1), whereas the expression pattern, similar to that observed for tPA and
PAI-1, with an amplification at the early time point ofexpression of uPA was not detectable by Northern blot-
ting (data not shown). To investigate whether the NO- 12 hours and inhibition at later time points (Fig. 1A).
The dose-dependencies of SNAP effects on tPA anddonor SNAP had any influence on the IL-1-induced
tPA mRNA level, the time-course of tPA mRNA induc- PAI-1 mRNA levels are depicted in Figure 2. At the
12-hour incubations, the addition of SNAP resulted in ation caused by IL-1 in the presence or absence of SNAP
(500 mol/L) was monitored. Figure 1A shows that further increase of IL-1-mediated mRNA accumulation
with maximal effects seen at 0.25 mmol/L of SNAP (Fig.SNAP alone had no or only a minor (at 12 hours) induc-
ing effect on basal tPA mRNA level, but it modulated 2A). At higher concentrations of SNAP (
0.5 mmol/L)
the extent of amplification decreased again. At the 12-IL-1-induced tPA mRNA level biphasically. At the ear-
liest time point tested (12 hours) SNAP potentiated the hour time point of stimulation, SNAP alone increased
tPA mRNA steady-state level. At the 24-hour time pointIL-1-stimulated tPA mRNA level, whereas at later time
points (24 and 36 hours), SNAP exerted a strong inhibi- of stimulation, the inhibitory action of SNAP on IL-1-
evoked tPA and PAI-1 mRNA levels was already seentory effect on the cytokine-induced tPA mRNA level.
The strongest inhibitory effects were observed at 36 at a concentration of 100 mol/L SNAP and a maximal
inhibition occurred at 1.0 mmol/L of SNAP (Fig. 2).hours of coincubation (60% inhibition of IL-1-induced
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Fig. 1. Effects of exogenous nitric oxide on the expression of the matrix
proteases tissue-type plasminogen activator (tPA) and matrix metallo-
proteinase-9 (MMP-9) and their endogenous inhibitors plasminogen
activator inhibitor-1 (PAI-1) and tissue inhibitor of metalloprotease-1
(TIMP-1) in rat mesangial cells (MCs). (A) Time-course of steady-state
levels of mRNA of tPA, PAI-1, MMP-9 and TIMP-1 in MCs following
treatment with vehicle (control) or interleukin-1 (IL-1; 2 nmol ·
L1) with or without S-nitroso-N-acetyl-D,L-penicillamine (SNAP; 500
mol/L). Twenty micrograms of total cellular RNA were hybridized
successively to the corresponding 32P-labeled cDNA inserts as described
in the Materials and Methods section. Equivalence of loading was
ascertained by rehybridization to a GAPDH probe. The blot is represen-
tative for two further independent experiments. Statistical analysis of
tPA (B) and PAI-1 (C ) mRNA levels after 36 hours of stimulation.
Data represent means SD (N 3). **P 0.01 compared with vehicle,
or IL-1-stimulated conditions (#P  0.05; ##P  0.01). (D) Time-
course of tPA levels in the cell culture supernatant following treatment
with vehicle (control) or IL-1 (2 nmol/L) with or without SNAP
(500 mol/L) as indicated. Data represent means  SD (N  3). *P 
0.05; **P 0.01 compared with vehicle, or IL-1-stimulated conditions
(##P  0.01).
Concentrations up to 0.5 mmol/L of SNAP had no effects
on cell viability (see above) and only at 1.0 mmol/L
SNAP was there a moderate increase in apoptosis of
MCs (data not shown), thus confirming previous obser-
vations [18]. To ensure that the effects observed were
specific for NO, we tested a second NO donor, DETA
NONOate. Both NO donors had comparable half-lives
under the experimental conditions used (16.5 to 20
hours) [19], which was similar to previously reported
data [20, 21]. The late inhibitory effects on the IL-1-
induced tPA and PAI-1 mRNA levels were similar inde-
pendent of the type of NO donor used (Fig. 3). Moreover,
at the early time point of stimulation DETA NONOate
by itself increased the basal tPA mRNA level, similar to
the effects with SNAP at the 12-hour time point (Fig. 2).
NO-dependent modulation of tPA/PAI-mRNA levels
results in a modulation of extracellular tPA activity
As demonstrated above, the cytokine-induced tPA
and PAI-1 mRNA levels in long-term stimulations were
similarly affected by exogenously applied NO. To test
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Table 1. Effects of SNAP and ROS on IL-1–triggered tPA activity
in cellular supernatants of MCs stimulated for 12 and 36 hours,
respectively, with the indicated agents
tPA activity tPA activity
Treatment (IU mL1) 12 h (IU mL1) 36 h
Vehicle 0.010.01 0.090.06
IL-1 2 nmol/L 2.270.12b 1.400.44b
SNAP 0.5 mmol/L 0.230.04a 0.070.03
IL-1SNAP 0.510.04ad 0.470.24ad
HXXO 8 mU·mL1 0.100.03a 0.160.06
IL-1HXXO 1.490.09bd 1.940.21bc
Data are means  SEM (N  3). Abbreviations are in the Appendix.
a P 	 0.05, b P 	 0.01 compared with vehicle
c P 	 0.05, d P 	 0.01 compared with IL-1–stimulated conditions
Fig. 2. Dose-dependent modulation of IL-1–induced steady-state
mRNA level of tPA and PAI-1 by SNAP. MCs were treated for 12
hours (A) and 24 hours (B) with the indicated concentrations of SNAP
in the absence () or presence () of 2 nmol · L1 of IL-1. The
blots were successively hybridized with the indicated 32P labeled cDNA
inserts. The data are representative for two independent experiments
with similar results.
Fig. 4. Inhibition of nitric oxide synthase (NOS) leads to a dose-depen-
dent increase of IL-1–induced tPA and PAI-1 mRNA levels. Quies-
cent MCs were cotreated for 48 hours with vehicle (control), IL-1
(2 nmol · L1) without () or with () the indicated concentrations of
L-NMMA. Twenty micrograms of total cellular RNA were hybridized
successively to 32P-labeled cDNA inserts from rat tPA and PAI-1 genes,
respectively. The experiment is representative for three experiments
giving similar results. The levels of nitrite in the corresponding cell
supernatants are shown at the bottom.
for 12 and 36 hours, respectively. SNAP significantly re-
duced the IL-1-caused increase of tPA activity at both
time points tested (Table 1). This contrasts, in part, to
the expression pattern of tPA mRNA, but is in a full
agreement to the NO-mediated effects on the tPA anti-
gen level measured in the conditioned media (Fig. 1D).
Obviously, the early increase of tPA mRNA by SNAPFig. 3. Time-course of tPA and PAI-1 mRNA levels in MCs stimulated
with IL-1 or DETA NONOate. MCs were incubated for the indicated does not translate into changes in tPA enzyme activity.
time periods with vehicle (control), IL-1 (2 nmol · L1), DETA-
NONOate (DETA-NO, 500 mol/L) or combinations of IL-1 plus Amplification of IL-1-stimulated expression of tPADETA-NONOate. Twenty micrograms of total cellular RNA were hy-
and PAI-1 by inhibition of iNOSbridized successively to the corresponding 32P-labeled cDNA inserts.
The data shown are representative for two independent experiments To evaluate the potential regulatory role of endoge-giving similar results
nously produced NO on tPA and PAI-1 expression, MCs
were treated with IL-1 in the absence or presence of
L-NMMA, a specific inhibitor of NO synthase activity.
whether this resulted in a change in tPA enzyme activity, IL-1 is a primary trigger of iNOS expression in MCs,
tPA activity in the cell culture supernatants was analyzed and results in a large and sustained production of NO
by ELISA. Equal amounts of conditioned media from [22, 23]. As shown in Figure 4, the IL-1–caused in-
MCs either treated with vehicle or with IL-1 in the ab- crease in tPA mRNA level was substantially amplified
by L-NMMA. The amplification occurred in a dose-sence or presence of 500 mol/L SNAP were assessed
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Fig. 5. DETA-NONOate increases the half-
life of IL-1-induced tPA mRNA. (A) Quies-
cent MCs were treated for 16 hours with IL-1
(2 nmol · L1) in the presence or absence of
DETA NONOate (500 mol/L) before acti-
nomycin D (10 g · mL1) was added to the
culture dish (0 hour) and incubated further
for the time points indicated. Subsequently,
MCs were harvested and extracted for total
RNA. Fifteen micrograms of total cellular RNA
were hybridized to a 32P-labeled tPA probe.
The equal loading of RNA was ascertained
by subsequent hybridization to a 32P-labeled
18S rRNA probe. (B) A densitometrical anal-
ysis of changes in the half-life of tPA mRNA
is shown in the lower panel. The tPA mRNA
levels from cells treated with IL-1 in the pres-
ence ( ) or absence () of DETA-NONOate,
and harvested before the addition of actino-
mycin D (0 hour) were set as 100%. The data
shown are representative for two experiments
giving similar results.
dependent manner with a maximal stimulatory effect Role of cGMP in the NO-modulation of tPA mRNA
seen with 3.0 mmol/L of L-NMMA (Fig. 4). At this con- Many physiological actions of NO are mediated by the
centration the inhibition of iNOS activity assessed by activation of soluble guanylate cyclase, which results in
measurement of nitrite was complete (Fig. 4) and cell an increase in intracellular cGMP level [25, 26]. To test
viability was not affected [24]. The same blot was stripped whether cGMP could mimic either the stimulatory or the
and rehybridized with a PAI-1 specific probe, and showed inhibitory effects observed after NO treatment on tPA
a similar potentiation of PAI-1 mRNA (Fig. 4). L-NMMA mRNA level, MCs were incubated with IL-1, either in
tested at the highest concentration (3 mmol/L) had no the presence or absence of the membrane-permeable
effects on basal mRNA levels of tPA or PAI-1. These cGMP analog dibutyryl cGMP, for 12 and 24 hours,
data indicate that the cytokine-induced increase of steady- respectively (Fig. 6). Most interestingly, the effects of
state level of tPA and PAI-1 mRNA is negatively modu- dibutyryl cGMP were strictly time-dependent. At the
lated by endogenous NO production. 12-hour time point, cGMP at all concentrations tested
A further experiment tested whether exogenous addi- strongly amplified the IL-1–induced tPA mRNA with-
tion of NO modulates the half-life of IL-1–induced tPA out changing the basal tPA mRNA levels (Fig. 6). In
mRNA. Experiments were performed using actinomycin contrast, at the 24-hour time point cGMP failed to al-
D, a potent inhibitor of eukaryotic gene transcription. ter basal or IL-1–induced tPA mRNA levels (Fig. 6).
MCs were treated with IL-1 in the presence or absence These findings suggest that the early amplification of
of 0.5 mmol/L DETA-NONOate for 16 hours, before cytokine-induced tPA by NO donors is potentially medi-
cells were exposed to actinomycin D (10 g · mL1). ated by cGMP, whereas the late inhibition of cytokine-
After different time points (1, 2, 4, 6, 8 and 12 hours) induced tPA by NO is independent of cGMP-mediated
cells were harvested for total RNA extraction. Possible signaling pathways.
changes in tPA mRNA stability were assessed by North-
ROS augment the IL-1–induced tPA and PAI-1ern blot analysis by measuring the amount of tPA mRNA
mRNA steady-state levels and tPA activitylevel after each time point (Fig. 5). The treatment with
DETA NONOate caused an overall reduction in tPA Finally, we evaluated whether ROS also could alter
steady-state mRNA level despite the fact that the half- the IL-1–induced mRNA level of tPA. Comparable to
life of tPA RNA was increased by DETA NONOate NO, ROS are considered to represent key players of
(Fig. 5). This points to regulatory effects of NO on tran- inflammatory processes including those in the kidney
[27, 28]. The production of ROS is catalyzed by severalscriptional and post-transcriptional processes.
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monitored the time-course of tPA mRNA induction caused
by IL-1 in the presence or absence of ROS (Fig. 7B).
Potentiating effects on IL-1 induced tPA mRNA by
ROS were observed after 8 hours, but not at 4 hours of
treatment, and reached a maximum at 24 hours (Fig. 7B).
Generation of O2 in aqueous solutions is accompanied
by a rapid dismutation to H2O2 by the action of SOD
[29]. We therefore checked whether the amplification of
IL-1-induced tPA expression by HXXO is affected by
SOD mimetics. As shown in Figure 8, coincubation of
MCs with IL-1 plus HXXO and different concentra-
tions of MnTBAP, a membrane-permeable SOD mimetic,
did not affect the amplification of cytokine-induced tPA
expression by HXXO. This demonstrates that dismuta-
tion of O2 to H2O2 does not prevent the amplification
of tPA expression by ROS (Fig. 8). A further approach
tested whether glucose oxidase, which catalyzes a H2O2
generating reaction is able to mimic the potentiation of
IL-1–triggered tPA expression. As shown in Figure 8,
the addition of glucose oxidase caused a marked increase
in IL-1–triggered tPA mRNA level. The effects of Mn-Fig. 6. Early amplification but not the late suppression of IL-1-
TBAP and glucose oxidase on the IL-1–induced PAI-1induced tPA mRNA level by NO is mimicked by cGMP. MCs were
stimulated for 12 hours (A) and 24 hours (B) with the indicated concen- mRNA were similar to those found for tPA (Fig. 8). These
trations of dibutyryl cGMP in the absence () or presence () of data clearly indicate that H2O2, but not O2 , is the mediator2 nmol · L1 of IL-1, as indicated. Twenty micrograms of total cellular
of ROS-modulation of tPA and PAI-1 expression.RNA were successively hybridized to 32P-labeled tPA and GAPDH
probes. The data shown are representative of two experiments giving
similar results. Amplification of IL-1-triggered tPA and PAI-1
mRNA levels by H2O2
To further evaluate this hypothesis, MCs were treated
enzymes, including NADPH oxidases, which in turn are with different concentrations of H2O2 (10, 30 and 100
activated by a variety of stimuli, including bacterial prod- mol/L) in the presence or absence of IL-1 (Fig. 9A).
ucts [such as lipopolysaccharide (LPS)] and inflamma- The addition of H2O2 caused a clear increase in tPA and
tory cytokines [for example, interferon- (IFN-), IL-1, PAI-1 mRNA steady-state levels at all concentrations
TNF-, and IL-8] [27]. The primary product of the reac- tested without affecting the basal expression levels of
tion catalyzed by the NADPH oxidase is superoxide tPA or PAI-1.
(O2 ), which is converted to H2O2 by the action of diverse To corroborate that H2O2 is the main candidate signal,
superoxide dismutases (SOD) [29]. Two different O2 gen- we checked whether catalase could inhibit the ROS-medi-
erating systems were tested: the xanthine oxidase-system ated increase in IL-1–induced tPA mRNA level. MCs
(HXXO) with its substrate hypoxanthine and the redox simultaneously treated with IL-1, HXXO and different
cycler dimethylmethoxy-naphtochinone (DMNQ). Co- concentrations of catalase (100, 300 and 1000 U · mL1)
incubation of MCs with IL-1 and either xanthine oxidase displayed significant reduced levels of tPA and PAI-1
(8 mU/mL) and hypoxanthine (50 mol/L) or, alterna- mRNAs, respectively, when compared to the mRNA lev-
tively, with DMNQ (5 mol/L) resulted in a marked in- els of cells treated without catalase (Fig. 9B). Moreover,
crease of the tPA mRNA level induced by IL-1 (Fig. 7A). the addition of catalase dose-dependently attenuated the
The effects of both superoxide generating compounds increase of tPA and PAI-1 mRNA triggered by IL-1
alone on the basal tPA mRNA level were negligible (Fig. 9B). These data indicate that the cytokine-triggered
(Fig. 7A). The modulatory effects of ROS on the IL-1- increase in tPA and PAI-1 mRNA accumulation pre-
triggered PAI-1 mRNA level were less distinct when dominantly depends on the formation of H2O2.
compared to those seen with tPA mRNA. The augmen-
tation of tPA mRNA steady-state level was accompanied
DISCUSSIONby a corresponding increase in tPA activity in the cell
This study examined the potential role of NO in thesupernatants only at the late time-point (Table 1, 36 hours)
modulation of the tPA/PAI-system in glomerular MCs.but not at the early time-point tested (Table 1, 12 hours).
Upon stimulation with inflammatory cytokines, theseBoth O2 generating systems had no direct influence on
tPA-enzyme activity in vitro (data not shown). We also cells express the iNOS isoform resulting in a sustained
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Fig. 7. (A) Effects of superoxide generators
on IL-1-induced tPA and PAI-1 mRNA
steady-state levels. MCs were incubated for
24 hours with vehicle, 2 nmol · L1 IL-1, in
the presence () or absence () of the hypo-
xanthine/xanthine oxidase (HXXO) system at
8 mU · mL1, or, alternatively, the redox cycler
dimethoxy-1,4-naphtoquinone (DMNQ) at 5
mol/L as indicated. Twenty micrograms of
total cellular RNA were successively hybrid-
ized to 32P-labeled tPA, PAI-1 and GAPDH
probes, respectively. (B) Time-course of am-
plification of IL-1-induced tPA mRNA lev-
els by HXXO. MCs were incubated for the
indicated time points with vehicle (control),
2 nmol · L1 IL-1 in the presence or absence
the hypoxanthine/xanthine oxidase system
(HXXO) at 8 mU · mL1 as indicated. Twenty
micrograms of total cellular RNA was succes-
sively hybridized to a 32P-labeled tPA and a
probe for 18S ribosomal RNA, respectively.
The data are representative for two indepen-
dent experiments giving similar results.
Fig. 8. Effects of HXXO on tPA mRNA levels are not affected by
coincubation with SOD, but are mimicked by glucose oxidase. MCs
were treated for 24 hours with 2 nmol · L1 IL-1 in the presence or
absence of MnTBAP at 10 and 100 mol/L, a cell-permeable SOD
mimetic, or alternatively with 200 mol/L H2O2 or 1 mmol/L glucose
oxidase as indicated. Twenty micrograms of total cellular RNA were
successively hybridized to 32P-labeled tPA, PAI-1 and a probe for 18S
ribosomal RNA, respectively. The data are representative of two inde-
pendent experiments giving similar results.
formation of high levels of NO [22–24]. Initially we con-
sidered these high levels of NO as being solely toxic
and deleterious for different cell types in the course of
Fig. 9. (A) Dose-dependency of H2O2 effects on IL-1–stimulated tPAglomerulonephritis [3]. However, more recently we dis-
and PAI-1 mRNA levels. MCs were incubated for 24 hours with vehicle,covered that NO is a master modulator of gene expres- 2 nmol · L1 IL-1 in the presence of the indicated concentrations
sion as well [14]. Several studies have demonstrated that of H2O2. Twenty micrograms of total cellular RNA were successively
hybridized to 32P-labeled tPA, PAI-1 and GAPDH probes, respectively.NO can alter the expression of genes and their products
The data are representative for two independent experiments givingthat are potentially involved in the pathogenesis of glo- similar results. (B) Catalase attenuates cytokine-and ROS-mediated
merulonephritis including genes for extracellular matrix induction of tPA and PAI-1 mRNA steady-state level. Quiescent MCs
were treated for 24 hours with vehicle (control), IL-1 or IL-1 plusproteins [30, 31] and the corresponding proteases [11,
HXXO in the presence of the indicated concentrations of catalase.16, 32]. Our present study found that NO given exoge- Twenty micrograms of total cellular RNA were hybridized successively
nously by NO-donors, which have weak effects on their to 32P-labeled tPA, PAI-1 and 18S ribosomal RNA probes. The data are
representative of two independent experiments giving similar results.own, could significantly reduce the cytokine-induced
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mRNA level of tPA and its cognate inhibitor PAI-1. The strated in human mesangial cells [36]. Moreover, a co-
ordinate up-regulation of both tPA and PAI-1 mRNAfact that the IL-1-induced expression of tPA and PAI-1
is amplified in the presence of L-NMMA proves that expression by glucocorticoids has been demonstrated in
rat hepatoma cells, although in these cells the net out-endogenous NO also is a potent modulator of this pro-
teolytic system, and in this way NO may exert tonic come is a glucocorticoid-mediated inhibition of tPA ac-
tivity [37]. The overall low tPA activity we measured ininhibitory effects on the expression of tPA and PAI-1
during the course of inflammatory kidney diseases. the cellular supernatants points to the high activity of
PAIs in MCs. Unfortunately, we could not monitor theThe PA system is crucially involved in the regulation
of the glomerular matrix turnover [4]. Moreover, plasmin level of PAI-1 antigen due to the lack of an antibody
specific for rat PAI-1. The coordinate regulation of ex-can activate latent elastases and MMPs and thus directly
triggers MMP activity [8]. We have recently shown that pression of a protease and its corresponding endogenous
inhibitor by NO may be of considerable physiologicalendogenously produced NO significantly inhibits the cy-
tokine-induced steady-state mRNA level of MMP-9 and importance, as it guarantees a fine-tuned level of net
proteolytic activity that allows for subtle changes in totalits cognate inhibitor TIMP-1 in rat MCs [11]. Obviously,
NO seems to exert an overall inhibitory effect on the matrix turnover.
The molecular mechanisms by which NO affects genecytokine-activated matrix protease cascade. Moreover,
we have identified NO as a costimulatory factor in the expression remain largely unknown [14, 35]. Interest-
ingly, when testing a 2.3 kb of the promoter region ofexpression of inflammatory enzymes, including iNOS
and secretory phospholipase A2 [33, 34]. Therefore, in the rat tPA gene in a luciferase-reporter gene assay, we
found a further increase of the IL-1 induced promoterMCs, NO can negatively as well as positively modulate
cytokine-primed gene expression [14]. Physiologically, activation by DETA NONOate, instead of the expected
inhibitory effects (data not shown). Moreover, it is worththe stimulatory effects of NO on iNOS and sPLA2 ex-
pression may represent a mechanism by which cells rap- noting that the 3 flanking region of the rat tPA gene
bears several “AUUA” rich motifs that point to an addi-idly enhance their capacity of host-defense, which may
form the basis for the dramatic production of NO and tional regulation of mRNA stability. Using actinomycin
D, an inhibitor of eukaryotic gene transcription, surpris-prostaglandins seen in many acute inflammatory dis-
eases. In contrast, the inhibitory effects of NO on cyto- ingly we found that exogenous NO prolonged the half-
life of tPA mRNA (Fig. 5). Additional experimental workkine-induced tPA expression reported here may protect
the mesangium from excessive ECM-degradation pro- is required to evaluate more precisely the temporal aspects
of transcriptional and post-transcriptional regulation ofvoked by IL-1. Such a mechanism would constitute a
self-regulating signaling pathway that allows for a finely tPA expression by NO and ROS. An intriguing observa-
tion is reported in Figure 6, indicating that the earlytuned expression regulation of pro- and anti-inflamma-
tory mediator production. In this context it should be responses to NO are mediated by the cGMP pathway,
whereas the later effects are independent of cGMP andemphasized that the temporal organization of the NO
signal and the ability of cells to spatially resolve the may involve redox regulation by NO. Alternative modes
of action of NO may involve cross-talk with the signalingsignal will determine the net outcome [35].
One important step in regulating tPA enzyme activity pathways activated by cytokines [38]. NO-dependent acti-
vation of several mitogen-activated protein kinase path-is limiting the rate of secretion of tPA protein. Our study
demonstrates that the inhibitory effects of NO on the ways also targeted by cytokines has been demonstrated
in several cell types [39–41]. These NO-sensitive path-tPA mRNA level were paralleled by a reduction of tPA
activity in the supernatants of MCs already at 12 hours ways may contribute to the activation of nuclear factor-B
(NF-B) and activator protein-1 (AP-1), transcriptionalof treatment with NO donors. In our hands, NO donors
had no direct effects on tPA activity, thus suggesting that activators that are highly sensitive to changes in the cellu-
lar redox state [35, 42–44].NO-mediated inhibition of tPA activity primarily results
from alterations in tPA expression. In addition to regu- Finally, ROS can modulate the cytokine-induced tPA
expression. Several reports have suggested an importantlating the rate of tPA synthesis and secretion, the actual
rate of plasminogen activation depends on the rate of con- role for ROS, mainly derived from neutrophils, in isch-
emic renal injury by its influence on glomerular proteasesversion of the inactive proenzyme to the active enzyme
that is limited by the action of abundant protease inhibi- and antiproteases [45, 46]. Most surprisingly, we found
that in MCs, NO and ROS have opposing effects on tPAtors, mainly by the plasminogen activator inhibitors (PAIs).
We compared NO effects on cytokine-induced mRNA and PAI-1 mRNA levels, respectively, which is reminis-
cent to the opposing regulation of MMP-9 expressionlevels of tPA and PAI-1 and found that mRNA levels
of both genes follow a similar expression pattern. A similar by NO and O2 [11, 16]. Most interestingly, we noted an
important difference in the response of both matrix pro-induction of tPA and PAI-1 mRNA by the phorbol ester
PMA, an activator of protein kinase C, was demon- teases. Whereas the IL-1-induced increase in MMP-9
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sion in a model of immune complex-mediated glomerulonephritis.mRNA is drastically reduced by addition of SOD and
Am J Pathol 141:85–98, 1992
cannot be mimicked by H2O2, the superinduction of 7. Aya N, Yoshioka K, Murakami K, et al: Tissue-type plasminogen
activator and its inhibitor in human glomerulonephritis. J PatholIL-1-induced tPA mRNA by ROS is clearly related to
166:289–295, 1992H2O2 formation, but not to O2 . Therefore, possible ef- 8. Dano K, Andreasen PA, Grondahl-Hansen J, et al: Plasminogen
fects on the expression and activity of the O2 and H2O2 activators, tissue degradation, and cancer. Adv Cancer Res 44:139–
266, 1985decomposing enzymes SOD and catalase by NO may be
9. Liotta LA, Goldfarb RH, Brundage R, et al: Effect of plasmino-of considerable importance for the final impact on the
gen activator (urokinase), plasmin, and thrombin on glycoprotein
proteolytic cascade exerted by NO [47]. The ratio be- and collagenous components of basement membrane. Cancer Res
41:4629–4636, 1981tween NO and ROS is thought to be of great relevance
10. Saksela O: Plasminogen activation and regulation of pericellularfor the regulation of proinflammatory gene expression proteolysis. Biochim Biophys Acta 823:35–65, 1985
[35], and is critical for the decision of MCs to live or to 11. Eberhardt W, Beeg T, Beck KF, et al: Nitric oxide modulates
expression of matrix metalloproteinase-9 in rat mesangial cells.die by either apoptosis or necrosis [48]. The opposing
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ity within the mesangium may have important conse- of vascular endothelium. Effects on tissue-type plasminogen activa-
tor and type 1 plasminogen activator inhibitor. J Biol Chem 263:quences mainly under conditions of simultaneous pro-
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